Calendar AstraZeneca PLC Xetra

Equities

ZEG

GB0009895292

Market Closed - Xetra 11:35:31 2024-06-07 am EDT 5-day change 1st Jan Change
148.2 EUR 0.00% Intraday chart for AstraZeneca PLC +3.42% +21.42%

Chart calendar AstraZeneca PLC

c0ab028a56b0628fe0240f337.OFGhW8louSO9sOHokZUPX6iZAhDVbav84U4NU4o4N20.cRfYNYMu_kbXxILR6PR4DMrjW3SAIuaahgR-NslrRzsAO8d2kx3LVszGlg~e03b8a4fc1620ef815531d6074a65b61

Upcoming events on AstraZeneca PLC

2024-07-25 02:00 am Q2 2024 Earnings Release
2024-11-12 02:00 am Q3 2024 Earnings Release
2025-02-05 Q4 2024 Earnings Release (Projected)
2025-04-24 Q1 2025 Earnings Release (Projected)
2025-07-23 Q2 2025 Earnings Release (Projected)
2025-11-05 Q3 2025 Earnings Release (Projected)

Past events on AstraZeneca PLC

2024-06-03 08:30 pm Investor Meeting
2024-06-03 04:12 pm American Society of Clinical Oncology Meeting - Abstract No:LBA501
2024-06-03 02:30 pm American Society of Clinical Oncology Meeting - Abstract No:8046
2024-06-03 02:30 pm American Society of Clinical Oncology Meeting - Abstract No:8617
2024-06-03 02:30 pm American Society of Clinical Oncology Meeting - Abstract No :8593
2024-06-03 02:30 pm American Society of Clinical Oncology Meeting - Abstract No:8623
2024-06-03 02:30 pm American Society of Clinical Oncology Meeting - Abstract No :8548
2024-06-03 02:30 pm American Society of Clinical Oncology Meeting - Abstract No :8543
2024-06-03 11:51 am American Society of Clinical Oncology Meeting - Abstract No:4019
2024-06-03 10:12 am American Society of Clinical Oncology Meeting - Abstract No:8005
2024-06-02 05:36 pm American Society of Clinical Oncology Meeting - Abstract No:8011
2024-06-02 05:24 pm American Society of Clinical Oncology Meeting - Abstract No:1006
2024-06-02 04:21 pm American Society of Clinical Oncology Meeting - Abstract No:LBA5
2024-06-02 03:47 pm American Society of Clinical Oncology Meeting - Abstract No:LBA4
2024-06-02 10:00 am American Society of Clinical Oncology Meeting - Abstract No:1025
2024-06-02 08:30 am American Society of Clinical Oncology Meeting - Abstract No:LBA1000
2024-06-01 06:24 pm American Society of Clinical Oncology Meeting - Abstract No:1009
2024-06-01 02:39 pm American Society of Clinical Oncology Meeting - Abstract No:5510
2024-06-01 02:30 pm American Society of Clinical Oncology Meeting - Abstract No:TPS4182
2024-06-01 02:30 pm American Society of Clinical Oncology Meeting - Abstract No:TPS4187

Past dividends on AstraZeneca PLC

2024-02-21 Final Payment 1.56 GBP
2023-08-09 Interim Payment 0.718 GBP
2023-02-22 Final Payment 1.628 GBP
2022-08-10 Interim Payment 0.764 GBP
2022-02-23 Final Payment 1.453 GBP
2021-08-11 Interim Payment 0.648 GBP
2021-02-24 Final Payment 1.374 GBP
2020-08-12 Interim Payment 0.696 GBP
2020-02-26 Final Payment 1.464 GBP
2019-08-07 Interim Payment 0.719 GBP

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
24 384
24 440
-0.23%
26 617
26 378
0.91%
37 417
36 239
3.25%
44 351
44 465
-0.26%
45 811
45 716
0.21%

51 620

EBITDA
Million USD
Released
Forecast
Spread
6 686
6 882
-2.84%
8 311
8 087
2.76%
7 586
10 816
-29.87%
9 237
13 681
-32.49%
13 580
15 477
-12.26%

17 920

EBIT
Million USD
Released
Forecast
Spread
6 436
6 631
-2.95%
7 340
7 417
-1.04%
9 928
10 003
-0.75%
13 350
13 702
-2.57%
14 534
15 036
-3.34%

16 821

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
1 548
2 130
-27.34%
3 916
4 387
-10.74%
-265
1 510
-117.55%
2 501
3 511
-28.78%
6 899
9 269
-25.57%

11 091

Net income
Million USD
Released
Forecast
Spread
1 335
1 895
-29.55%
3 196
2 930
9.09%
112
2 055
-94.55%
3 288
4 262
-22.86%
5 961
6 597
-9.64%

8 844

EPS
USD
Released
Forecast
Spread
1,03
1,41
-26.77%
2,44
2,50
-2.26%
0,08
1,99
-95.98%
2,11
2,81
-24.96%
3,81
4,34
-12.22%

5,67

Announcement Date14/02/2011/02/2110/02/2209/02/2308/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
11 390
10 967
3.86%
10 771
10 577
1.83%
10 982
10 848
1.23%
11 207
11 287
-0.71%
10 879
10 559
3.03%
11 416
11 018
3.62%
11 492
11 529
-0.32%
12 024
12 007
0.14%
12 679
11 812
7.34%

12 574


12 972


13 475


13 410


13 730

EBITDA
Million USD
Released
Forecast
Spread
2 187
3 894
-43.83%
1 896
5 337
-64.47%
2 579
2 556
0.88%
2 574
2 966
-13.22%



3 732
4 074
-8.39%










4 396


4 404


5 260







EBIT
Million USD
Released
Forecast
Spread
3 961
3 486
13.62%
3 365
3 291
2.25%
3 413
3 189
7.03%
2 610
2 916
-10.5%
3 946
3 517
12.21%
4 291
4 005
7.13%
3 545
3 537
0.24%
2 752
3 206
-14.15%
4 310
3 911
10.2%

4 027


4 356


3 974







Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
553
972
-43.08%
247
580
-57.38%
922
1 007
-8.4%
778
806
-3.47%
2 262
1 834
23.34%
2 088
2 410
-13.36%
1 652
2 510
-34.17%
897
1 671
-46.32%
2 800
2 296
21.95%

2 361


2 740


3 099







Net income
Million USD
Released
Forecast
Spread
386
1 086
-64.45%
360
946
-61.96%
1 640
895
83.16%
901
2 096
-57.02%
1 803
1 594
13.14%
1 818
2 123
-14.37%
1 378
1 705
-19.16%
959
2 313
-58.53%
2 179
2 065
5.52%

2 092


2 450


2 493







EPS
USD
Released
Forecast
Spread
0,25
0,70
-64.25%
0,23
0,78
-70.61%
1,05
0,58
82.48%
0,58
1,35
-57.11%
1,16
1,08
7.44%
1,17
1,36
-14.03%
0,89
1,09
-18.64%
0,62
1,49
-58.3%
1,41
1,33
6.28%

1,34


1,57


1,60







Announcement Date29/04/2229/07/2210/11/2209/02/2327/04/2328/07/2309/11/2308/02/2425/04/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise